Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
94.04
-0.57 (-0.60%)
Apr 28, 2025, 12:01 PM EDT - Market open
Merit Medical Systems Revenue
Merit Medical Systems had revenue of $355.35M in the quarter ending March 31, 2025, with 9.84% growth. This brings the company's revenue in the last twelve months to $1.39B, up 8.19% year-over-year. In the year 2024, Merit Medical Systems had annual revenue of $1.36B with 7.89% growth.
Revenue (ttm)
$1.39B
Revenue Growth
+8.19%
P/S Ratio
3.98
Revenue / Employee
$187,616
Employees
7,400
Market Cap
5.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.36B | 99.15M | 7.89% |
Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
MMSI News
- 3 days ago - Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Merit Medical Launches the Ventrax™ Delivery System - GlobeNewsWire
- 20 days ago - Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025 - GlobeNewsWire
- 4 weeks ago - Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - GlobeNewsWire
- 4 weeks ago - Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - GlobeNewsWire
- 5 weeks ago - Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership - GlobeNewsWire
- 6 weeks ago - Merit Medical: A Success Story That Keeps Getting Better - Seeking Alpha
- 7 weeks ago - First Patient Enrolled in Merit Medical's PREEMIE Study - GlobeNewsWire